Abstract
Introduction and hypothesis
Interstitial cystitis (IC) and bladder pain syndrome (BPS) are challenging and encompassing hypersensitivity disorders of the lower urinary tract. A variety of national and international guidelines have been published including guidance on nomenclature, definitions, etiopathology, diagnostics and treatment. A lack of universally established clinical guidance is apparent. The aim of this review is to evaluate key guidelines on this area of practice, identify variations, compare their recommendations and grade them using AGREE II.
Methods
Literature searches were performed using the PUBMED and CINAHL database from January 1, 1983, to December 1, 2018, referring to the search strategy of AUA. Ten national and international guidelines were included into the analysis. We assessed the guidelines with the updated AGREE II.
Results
Symptoms congruent in all guidelines are: pain, pressure, discomfort and frequency, urgency and nocturia. Urinalysis is a prerequisite for diagnostics, cystoscopy for most and urodynamics not part of the routine assessment. Treatment options are recommended stepwise. The highest level of evidence and consensus was identified for oral therapies. Nine guidelines had an overall quality score ≥ 50% and three scored ≥ 70% (AUA, GG, RCOG).
Conclusions
The guidelines are congruent in symptom reporting, quite congruent in diagnostics and vary to a high degree on treatment recommendations. The complexity of BPS and emerging evidence indicate the need for regular updating of the guidelines and a wider consensus.
Similar content being viewed by others
References
Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases workshop on interstitial cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol. 1988;140(1):203–6.
Jones CA, Nyberg L. Epidemiology of interstitial cystitis. Urology. 1997;49(5A Suppl):2–9.
Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study. J Urol. 2013;189(1):141–5. https://doi.org/10.1016/j.juro.2012.08.088.
Davis NF, Gnanappiragasam S, Thornhill JA. Interstitial cystitis/painful bladder syndrome: the influence of modern diagnostic criteria on epidemiology and on internet search activity by the public. Transl Androl Urol. 2015;4(5):506–11. https://doi.org/10.3978/j.issn.2223-4683.2015.06.08.
Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–4. https://doi.org/10.1016/j.juro.2011.03.132.
Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L Jr. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health interstitial cystitis database study. J Urol. 1999;161(2):553–7.
Hanno P, Andersson KE, Birder L, Elneil S, Kanai A, Pontari M. Chronic pelvic pain syndrome/bladder pain syndrome: taking stock, looking ahead: ICI-RS 2011. Neurourol Urodyn. 2012;31(3):375–83. https://doi.org/10.1002/nau.22202.
van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7. https://doi.org/10.1016/j.eururo.2007.09.019.
Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, Messelink EJ, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2010;57(1):35–48. https://doi.org/10.1016/j.eururo.2009.08.020.
Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70. https://doi.org/10.1016/j.juro.2011.03.064.
Hanno PM, Erickson D, Moldwin R, Faraday MM, American Urological A. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545–53. https://doi.org/10.1016/j.juro.2015.01.086.
Cox A, Golda N, Nadeau G, Curtis Nickel J, Carr L, Corcos J, et al. CUA guideline: diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J. 2016;10(5-6):E136–55. https://doi.org/10.5489/cuaj.3786.
Homma Y, Ueda T, Ito T, Takei M, Tomoe H. Japanese guideline for diagnosis and treatment of interstitial cystitis. Int J Urol. 2009;16(1):4–16. https://doi.org/10.1111/j.1442-2042.2008.02208.x.
Homma Y, Ueda T, Tomoe H, Lin AT, Kuo HC, Lee MH, et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol. 2009;16(7):597–615. https://doi.org/10.1111/j.1442-2042.2009.02326.x.
Esteban M, Adot JM, Arlandis S, Peri L, Prieto L, Salinas J, et al. Recommendations for the diagnosis and management of bladder pain syndrome. Spanish Urological Association consensus document. Actas Urológicas Españolas (English Edition). 2015;39(8):465–72. https://doi.org/10.1016/j.acuroe.2015.07.002.
Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T, et al. Bladder pain syndrome Committee of the International Consultation on incontinence. Neurourol Urodyn. 2010;29(1):191–8. https://doi.org/10.1002/nau.20847.
Tirlapur SA, Ni Riordain R, Khan KS, Collaboration E-C. Variations in the reporting of outcomes used in systematic reviews of treatment effectiveness research in bladder pain syndrome. Eur J Obstet Gynecol Reprod Biol. 2014;180:61–7. https://doi.org/10.1016/j.ejogrb.2014.06.003.
Mishra NN. Clinical presentation and treatment of bladder pain syndrome/interstitial cystitis (BPS/IC) in India. Transl Androl Urol. 2015;4(5):512–23. https://doi.org/10.3978/j.issn.2223-4683.2015.10.05.
Wesselmann U. Chronic pelvic and urogenital pain syndromes. Pain. 2008;16(6):1–4.
Petrovic Z. Leitlinien Beckenschmerzsyndrom. J Urol Urogynäkol. 2012;19(4):15–21.
Tirlapur SA, Khan KS. An assessment of clinicians’ and patients’ experiences in the management of bladder pain syndrome. J Obstet Gynaecol. 2016;36(2):241–5. https://doi.org/10.3109/01443615.2015.1060200.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ. 2010;182(10):1045–52. https://doi.org/10.1503/cmaj.091714.
The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines. Bmj. 2016;354:i4852. https://doi.org/10.1136/bmj.i4852.
Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Updated by Howick J (March 2009). 2009. Available from: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.
Hanno P, Dmochowski R. Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn. 2009;28(4):274–86. https://doi.org/10.1002/nau.20687.
Hanno PM. Bladder pain syndrome (interstitial cystitis) and related disorders. In: Wein AJ, Kavoussi LR, Novick AC, et al., editors. Campbell-Walsh urology. 7th ed. Philadelphia: Saunders; 1998.
Warren JW, Meyer WA, Greenberg P, Horne L, Diggs C, Tracy JK. Using the International Continence Society's definition of painful bladder syndrome. Urology. 2006;67(6):1138–42; discussion 1142-1133. https://doi.org/10.1016/j.urology.2006.01.086.
O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997;49(5A Suppl):58–63.
Quaghebeur J, Wyndaele JJ. Comparison of questionnaires used for the evaluation of patients with chronic pelvic pain. Neurourol Urodyn. 2013;32(8):1074–9. https://doi.org/10.1002/nau.22364.
Rapariz-Gonzalez M, Castro-Diaz D, Mejia-Rendon D. Evaluation of the impact of the urinary symptoms on quality of life of patients with painful bladder syndrome/chronic pelvic pain and radiation cystitis: EURCIS study. Actas Urol Esp. 2014;38(4):224–31. https://doi.org/10.1016/j.acuro.2013.09.016.
Management of Bladder Pain Syndrome: Green-top Guideline No. 70. BJOG. 2017;124(2):e46–72. https://doi.org/10.1111/1471-0528.14310.
Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, et al. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type a for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol. 2008;53(6):1245–53. https://doi.org/10.1016/j.eururo.2008.02.037.
Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005;66(3):494–9. https://doi.org/10.1016/j.urology.2005.04.011.
Johansson SL, Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol. 1990;143(6):1118–24.
Palacios JL, Juarez M, Moran C, Xelhuantzi N, Damaser MS, Cruz Y. Neuroanatomic and behavioral correlates of urinary dysfunction induced by vaginal distension in rats. American Journal of Physiology Renal Physiology. 2016;310(10):F1065–73. https://doi.org/10.1152/ajprenal.00417.2015.
Luo D, Liu L, Han P, Wei Q, Shen H. Solifenacin for overactive bladder: a systematic review and meta-analysis. Int Urogynecol J. 2012;23(8):983–91. https://doi.org/10.1007/s00192-011-1641-7.
Astin JA. Why patients use alternative medicine—results of a national study. JAMA-J Am Med Assoc. 1998;279(19):1548–53. https://doi.org/10.1001/jama.279.19.1548.
Nickel JC, Irvine-Bird K, Jianbo L, Shoskes DA. Phenotype-directed management of interstitial cystitis/bladder pain syndrome. Urology. 2014;84(1):175–9. https://doi.org/10.1016/j.urology.2014.03.001.
Erickson DR, Propert KJ. Pregnancy and interstitial cystitis/painful bladder syndrome. The Urologic Clinics of North America. 2007;34(1):61–9. https://doi.org/10.1016/j.ucl.2006.10.006.
Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology. 1997;49(5A Suppl):14–40.
Okragly AJ, Niles AL, Saban R, Schmidt D, Hoffman RL, Warner TF, et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol. 1999;161(2):438–41 discussion 441-432.
Warren JW, Wesselmann U, Morozov V, Langenberg PW. Numbers and types of nonbladder syndromes as risk factors for interstitial cystitis/painful bladder syndrome. Urology. 2011;77(2):313–9. https://doi.org/10.1016/j.urology.2010.08.059.
Chuang YC, Weng SF, Hsu YW, Huang CL, Wu MP. Increased risks of healthcare-seeking behaviors of anxiety, depression and insomnia among patients with bladder pain syndrome/interstitial cystitis: a nationwide population-based study. Int Urol Nephrol. 2015;47(2):275–81. https://doi.org/10.1007/s11255-014-0908-6.
McKernan LC, Walsh CG, Reynolds WS, Crofford LJ, Dmochowski RR, Williams DA. Psychosocial co-morbidities in interstitial cystitis/bladder pain syndrome (IC/BPS): a systematic review. Neurourol Urodyn. 2018;37(3):926–41. https://doi.org/10.1002/nau.23421.
Rothrock NE, Lutgendorf SK, Hoffman A, Kreder KJ. Depressive symptoms and quality of life in patients with interstitial cystitis. J Urol. 2002;167(4):1763–7.
Reames BN, Krell RW, Ponto SN, Wong SL. Critical evaluation of oncology clinical practice guidelines. J Clin Oncol. 2013;31(20):2563–8. https://doi.org/10.1200/jco.2012.46.8371.
Shekelle PG, Ortiz E, Rhodes S, Morton SC, Eccles MP, Grimshaw JM, et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA. 2001;286(12):1461–7.
Kolata G. Program coaxes hospitals to see treatments under their noses. New York Times (December 25). 2004.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Details of ethics approval
There is no need for ethical approval for a systematic review.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
On behalf of CHORUS: An International Collaboration for Harmonising Outcomes, Research and Standards in Urogynaecology and Women’s Health
The paper was presented as a short podium presentation at the IUGA 2018 in Wien
Rights and permissions
About this article
Cite this article
Pape, J., Falconi, G., De Mattos Lourenco, T.R. et al. Variations in bladder pain syndrome/interstitial cystitis (IC) definitions, pathogenesis, diagnostics and treatment: a systematic review and evaluation of national and international guidelines. Int Urogynecol J 30, 1795–1805 (2019). https://doi.org/10.1007/s00192-019-03970-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-019-03970-5